Xiao-Bing Chen (Xiaobing Chen)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Ejection Fraction

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Top Venues

Technology in cancer research & treatment

Therapeutic advances in gastroenterology

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hui Wang, Caiyun Nie, Weifeng Xu, Jing Li, He Gou, Huifang Lv, Beibei Chen, Jianzheng Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer. Therapeutic advances in gastroenterology 17 (2024)
Huifang Lv, Caiyun Nie, Yunduan He, Beibei Chen, Yingjun Liu, Junling Zhang, Xiao-Bing Chen
Individual Irinotecan Therapy Under the Guidance of Pre-Treated UGT1A1 * 6 Genotyping in Gastric Cancer. Technology in cancer research & treatment 23 (2024)
Huifang Lv, Caiyun Nie, Yunduan He, Beibei Chen, Yingjun Liu, Junling Zhang, Xiao-Bing Chen
Individual Irinotecan Therapy Under the Guidance of Pre-Treated UGT1A1 * 6 Genotyping in Gastric Cancer. Technology in cancer research & treatment 23 (2024)
Huifang Lv, Caiyun Nie, Yunduan He, Beibei Chen, Yingjun Liu, Junling Zhang, Xiao-Bing Chen
Individual Irinotecan Therapy Under the Guidance of Pre-Treated UGT1A1 * 6 Genotyping in Gastric Cancer. Technology in cancer research & treatment 23 (2024)
Hui Wang, Caiyun Nie, Weifeng Xu, Jing Li, He Gou, Huifang Lv, Beibei Chen, Jianzheng Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer. Therapeutic advances in gastroenterology 17 (2024)
Hui Wang, Caiyun Nie, Weifeng Xu, Jing Li, He Gou, Huifang Lv, Beibei Chen, Jianzheng Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer. Therapeutic advances in gastroenterology 17 (2024)
Caiyun Nie, Huifang Lv, Beibei Chen, Weifeng Xu, Jianzheng Wang, Saiqi Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in cancer research & treatment 22 (2023)
Caiyun Nie, Huifang Lv, Beibei Chen, Weifeng Xu, Jianzheng Wang, Saiqi Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in cancer research & treatment 22 (2023)
Caiyun Nie, Huifang Lv, Beibei Chen, Weifeng Xu, Jianzheng Wang, Saiqi Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in cancer research & treatment 22 (2023)
Caiyun Nie, Huifang Lv, Beibei Chen, Weifeng Xu, Jianzheng Wang, Saiqi Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in cancer research & treatment 22 (2023)
Caiyun Nie, Huifang Lv, Beibei Chen, Weifeng Xu, Jianzheng Wang, Saiqi Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in cancer research & treatment 22 (2023)
Caiyun Nie, Huifang Lv, Beibei Chen, Weifeng Xu, Jianzheng Wang, Saiqi Wang, Yingjun Liu, Yunduan He, Jing Zhao, Xiao-Bing Chen
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in cancer research & treatment 22 (2023)
Jianzheng Wang, Jinxi Huang, Hui Wang, Wei Yang, Qiwen Bai, Zhentao Yao, Qingli Li, Huifang Lv, Beibei Chen, Caiyun Nie, Weifeng Xu, Shuiping Tu, Hongle Li, Xiao-Bing Chen
Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model. Journal of oncology 2022 (2022)
Jianzheng Wang, Baiwen Zhang, Xiaojiao Cheng, Qingli Li, Huifang Lv, Caiyun Nie, Beibei Chen, Weifeng Xu, Jing Zhao, Yunduan He, Shuiping Tu, Xiao-Bing Chen
Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors. Journal of oncology 2022 (2022)
Qi Sun, Yao Fu, Xiao-Bing Chen, Lin Li, Hongyan Wu, Yixuan Liu, Haojun Xu, Guoren Zhou, Xiangshan Fan, Hongping Xia
Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric Cancers. Gut and liver 16 (6) (2022)
Sai-Qi Wang, Kai-Rui Zhou, Xiao-Li Shi, Hui-Fang Lv, Liang-Yu Bie, Wei-Jie Zhao, Xiao-Bing Chen
Steroidal dimer by001 inhibits proliferation and migration of esophageal cancer cells via multiple mechanisms. Cancer chemotherapy and pharmacology 83 (1) (2018)